Proposal for Issuance of Convertible Corporate Bonds to Non-Specific Targets (Revised Draft)

Stock Abbreviation: Tailin Bioengineering Stock Code: 300813

ZheJiang Tailin Bioengineering Co., Ltd.

(No. 2930 Nanhuan Road, Binjiang District, Hangzhou)

Proposal for Issuance of Convertible Corporate Bonds to Non-Specific Targets (Revised Draft)

July 2026

Issuer Statement

1. The Company and all members of the Board of Directors guarantee that the information disclosed in this proposal is true, accurate, and complete, and confirm that there are no false records, misleading statements, or major omissions. They bear individual and joint legal responsibility for the authenticity, accuracy, and completeness of the contents of this proposal.

2. After this issuance of convertible corporate bonds to non-specific targets, the Company is solely responsible for changes in its operations and earnings; investors are solely responsible for investment risks arising from this issuance.

3. This proposal is the Board of Directors' explanation of this issuance of convertible corporate bonds to non-specific targets; any statement to the contrary is a false statement.

4. If investors have any questions, they should consult their brokers, lawyers, professional accountants, or other professional advisors.

5. The matters stated in this proposal do not represent a substantive judgment, confirmation, approval, or registration by the approval or registration authorities regarding the matters related to this issuance. The effectiveness and completion of this issuance are subject to the deliberation of the Company's general meeting of shareholders, the issuance and listing review by the Shenzhen Stock Exchange, and registration with the China Securities Regulatory Commission (CSRC). The final implementation shall be subject to the plan registered with the CSRC.

Table of Contents

Issuer Statement 1

Table of Contents 2

Definitions 3

I. Explanation of Compliance with Conditions for Issuance of Convertible Corporate Bonds to Non-Specific Targets 4

II. Overview of the Issuance 4

III. Financial Accounting Information and Management Discussion and Analysis 12

IV. Use of Proceeds from the Issuance 22

V. Company Profit Distribution Policy and Dividend Distribution 22

VI. Statement of the Board of Directors on the Absence of Dishonesty 26

VII. Statement of the Board of Directors on the Company's Refinancing Plan for the Next Twelve Months 26

Definitions

Unless otherwise specified, the following terms have the following meanings in this proposal: